Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
66.89
-1.71 (-2.49%)
At close: Nov 20, 2026, 4:00 PM EST
67.48
+0.59 (0.89%)
After-hours: Nov 20, 2026, 7:30 PM EST
Globus Medical Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Globus Medical stock has a consensus rating of "Buy" and an average price target of $93.43. The average 1-year stock price forecast is 39.68% higher than the current stock price, while the lowest is $75 (+12.12%) and the highest is $110 (+64.45%).
Price Target: $93.43 (+39.68%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 7 | 6 |
| Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Hold | 4 | 5 | 5 | 5 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 15 | 15 | 15 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 7, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $100 → $90 | Buy | Reiterates | $100 → $90 | +34.55% | Nov 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $100 | Buy | Reiterates | $100 | +49.50% | Nov 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $99 → $100 | Buy | Reiterates | $99 → $100 | +49.50% | Nov 6, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $85 | Buy | Reiterates | $85 | +27.07% | Nov 6, 2026 |
Financial Forecast
Revenue This Year
3.11B
from 2.94B
Increased by 5.77%
Revenue Next Year
3.28B
from 3.11B
Increased by 5.50%
EPS This Year
4.98
from 3.98
Increased by 25.12%
EPS Next Year
5.34
from 4.98
Increased by 7.17%
EPS and Forward PE are based on non-GAAP adjusted numbers.